ARK Genomic Revolution ETF (BATS:ARKG), Trade Ideas

ARK Genomic Revolution Multi-Sector ETF

Photo courtesy of Ark Invest.

News

Short Sellers

Specialty ETFs

New ETFs

Markets

Tech

ETFs

ARKF

ARKG

ARKK

ARKQ

ARKW

ARKX

COIN

HOOD

PATH

RBLX

ROKU

SARK

TARK

TSLA

CSRP

In early 2021, Cathie Wood&#39;s ARK Invest managed $59B across 6 funds, becoming the world&#39;s largest active ETF manager. However, by April 2024, heavy outflows and underperforming holdings have caused assets under management to plummet to $11.1B.

Cathie Wood&#39;s Ark Empire Bleeds As Investor Outflows Spike: &#39;The Loyal Shareholders Have Become Frustrated&#39;

cathie-wood-bz-ark

Equities

$BTC

DKNG

NVDA

TDOC

TWLO

On Monday, Cathie Wood-led Ark Invest made significant trades involving Coinbase Global Inc. (NASDAQ:COIN) and NVIDIA Corp. (NASDAQ:NVDA). 



The COIN Trade

Cathie Wood&#39;s Ark Invest Continues To Shed Coinbase, Nvidia Shares

Ark Invest Photo by viewimage on Shutterstock

Long Ideas

Trading Ideas

PLTR

Roku is the third biggest holding of Ark&#39;s flagship ARKK exchange-traded fund.

Cathie Wood&#39;s Ark Buys Roku, Palantir And $1M Worth Of Stock In This Healthcare Company

ARK Genomic Revolution ETF

<p>Wells Fargo  analyst Daniel Politzer   maintains Royal Caribbean Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RCL#NYSE">RCL</a>) with a Overweight and raises the price target from $153 to $159.</p>


Price Target

Analyst Ratings

Wells Fargo Maintains Overweight on Royal Caribbean Gr, Raises Price Target to $159

<p>Wells Fargo   maintains Boyd Gaming (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BYD#NYSE">BYD</a>) with a Overweight and lowers the price target from $82 to $71.</p>


Wells Fargo Maintains Overweight on Boyd Gaming, Lowers Price Target to $71

<p>Investors with a lot of money to spend have taken a bearish stance on <strong>Caterpillar</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAT#NYSE">CAT</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with CAT, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 19 uncommon options trades for Caterpillar.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 36% bullish and 47%, bearish.</p>
<p>Out of all of the special options we uncovered, 9 are puts, for a total amount of $495,846, and 10 are calls, for a total amount of $788,888.</p>
<h3>What's The Price Target?</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $315.0 to $400.0 for Caterpillar during the past quarter. </p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>In today's trading context, the average open interest for options of Caterpillar stands at 609.88, with a total volume reaching 2,386.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Caterpillar, situated within the strike price corridor from $315.0 to $400.0, throughout the last 30 days.</p>
<h3>Caterpillar Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1714155384_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th style="text-align: right;"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>CAT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/17/24</td>
<td>$7.35</td>
<td>$7.15</td>
<td>$7.2</td>
<td>$347.50</td>
<td>$360.0K</td>
<td>25</td>
<td style="text-align: right;">567</td>
</tr>
<tr>
<td>CAT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$50.25</td>
<td>$48.95</td>
<td>$49.73</td>
<td>$340.00</td>
<td>$99.4K</td>
<td>351</td>
<td style="text-align: right;">23</td>
</tr>
<tr>
<td>CAT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/17/24</td>
<td>$63.8</td>
<td>$59.0</td>
<td>$63.8</td>
<td>$400.00</td>
<td>$95.7K</td>
<td>36</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>CAT</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/19/24</td>
<td>$20.9</td>
<td>$18.05</td>
<td>$18.63</td>
<td>$350.00</td>
<td>$83.8K</td>
<td>1.2K</td>
<td style="text-align: right;">2</td>
</tr>
<tr>
<td>CAT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>05/24/24</td>
<td>$20.45</td>
<td>$19.65</td>
<td>$19.99</td>
<td>$330.00</td>
<td>$76.0K</td>
<td>5</td>
<td style="text-align: right;">38</td>
</tr>
</tbody>
</table>
</p>
<h3>About Caterpillar</h3>
<p>Caterpillar is the premier manufacturer of heavy equipment, power solutions, and locomotives. It is currently the world's largest manufacturer of heavy equipment with over 13% market share in 2021. The company is divided into four reportable segments: construction industries, resource industries, energy and transportation, and Caterpillar Financial Services. Its products are available through a dealer network that covers the globe with about 2,700 branches maintained by 160 dealers. Caterpillar Financial Services provides retail financing for machinery and engines to its customers, in addition to wholesale financing for dealers, which increases the likelihood of Caterpillar product sales.</p>
<p>Having examined the options trading patterns of Caterpillar, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Caterpillar's Current Market Status</h3>
<ul>
<li>With a volume of 1,760,377, the price of CAT is up 1.95% at $344.58. </li>
<li>RSI indicators hint that the underlying stock may be approaching oversold.</li>
<li>Next earnings are expected to be released in 95 days.</li>
</ul>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Caterpillar options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


Options

This Is What Whales Are Betting On Caterpillar

<p>Investors with a lot of money to spend have taken a bullish stance on <strong>Wingstop</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WING#NASDAQ">WING</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with WING, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 18 uncommon options trades for Wingstop.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 44% bullish and 44%, bearish.</p>
<p>Out of all of the special options we uncovered, 5 are puts, for a total amount of $1,500,341, and 13 are calls, for a total amount of $2,249,746.</p>
<h3>Expected Price Movements</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $230.0 to $460.0 for Wingstop over the recent three months. </p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.</p>
<p>This data can help you track the liquidity and interest for Wingstop's options for a given strike price.</p>
<p>Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Wingstop's whale activity within a strike price range from $230.0 to $460.0 in the last 30 days. </p>
<h3>Wingstop 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1714155379_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th style="text-align: right;"><strong>Open Interest</strong></th>
<th style="text-align: right;"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>WING</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$37.0</td>
<td>$36.2</td>
<td>$36.4</td>
<td>$350.00</td>
<td>$1.2M</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">352</td>
</tr>
<tr>
<td>WING</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$36.9</td>
<td>$36.5</td>
<td>$36.8</td>
<td>$450.00</td>
<td>$1.1M</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">311</td>
</tr>
<tr>
<td>WING</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$54.4</td>
<td>$51.9</td>
<td>$52.5</td>
<td>$410.00</td>
<td>$393.7K</td>
<td style="text-align: right;">82</td>
<td style="text-align: right;">75</td>
</tr>
<tr>
<td>WING</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/21/24</td>
<td>$19.5</td>
<td>$18.6</td>
<td>$19.5</td>
<td>$400.00</td>
<td>$159.9K</td>
<td style="text-align: right;">856</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>WING</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$43.7</td>
<td>$43.1</td>
<td>$43.1</td>
<td>$300.00</td>
<td>$107.7K</td>
<td style="text-align: right;">7</td>
<td style="text-align: right;">65</td>
</tr>
</tbody>
</table>
</p>
<h3>About Wingstop</h3>
<p>Founded in 1994 in Garland, Texas, Wingstop is a restaurant operator specializing in indulgent bone-in and boneless chicken wings, chicken tenders, fries, and, recently, chicken sandwiches. The firm's footprint has grown quickly since its inception, reaching north of 2,200 global stores at the end of 2023, rendering Wingstop the 31st-largest restaurant brand in the U.S. by system sales, according to Euromonitor data. With a 98% franchised model, Wingstop generates the lion share of its revenue from franchise royalties and advertising fees, with the remainder derived from a small footprint of company-owned stores.</p>
<p>In light of the recent options history for Wingstop, it's now appropriate to focus on the company itself. We aim to explore its current performance.</p>
<h3>Current Position of Wingstop</h3>
<ul>
<li>With a volume of 262,986, the price of WING is up 3.54% at $383.0. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 5 days.</li>
</ul>
<h3>What Analysts Are Saying About Wingstop</h3>
<p>5 market experts have recently issued ratings for this stock, with a consensus target price of $353.4.</p>
<ul>
<li>An analyst from Truist Securities persists with their Hold rating on Wingstop, maintaining a target price of $307. </li>
<li>An analyst from TD Cowen has revised its rating downward to Buy, adjusting the price target to $410. </li>
<li>An analyst from Jefferies has decided to maintain their Hold rating on Wingstop, which currently sits at a price target of $335. </li>
<li>Maintaining their stance, an analyst from Wedbush continues to hold a Outperform rating for Wingstop, targeting a price of $400. </li>
<li>Consistent in their evaluation, an analyst from Morgan Stanley keeps a Equal-Weight rating on Wingstop with a target price of $315. </li>
</ul>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Wingstop options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


WING

Wingstop's Options: A Look at What the Big Money is Thinking

<p>Investors with a lot of money to spend have taken a bullish stance on <strong>Devon Energy</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DVN#NYSE">DVN</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with DVN, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 15 uncommon options trades for Devon Energy.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 53% bullish and 26%, bearish.</p>
<p>Out of all of the special options we uncovered, 5 are puts, for a total amount of $344,668, and 10 are calls, for a total amount of $607,437.</p>
<h3>Predicted Price Range</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $47.5 and $55.0 for Devon Energy, spanning the last three months.</p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>In terms of liquidity and interest, the mean open interest for Devon Energy options trades today is 5118.3 with a total volume of 3,326.00.</p>
<p>In the following chart, we are able to follow the development of volume and open interest of call and put options for Devon Energy's big money trades within a strike price range of $47.5 to $55.0 over the last 30 days.</p>
<h3>Devon Energy Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1714155373_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th style="text-align: right;"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>DVN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/21/24</td>
<td>$6.0</td>
<td>$5.95</td>
<td>$5.95</td>
<td>$47.50</td>
<td>$208.4K</td>
<td>6.8K</td>
<td style="text-align: right;">586</td>
</tr>
<tr>
<td>DVN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/20/24</td>
<td>$5.1</td>
<td>$5.0</td>
<td>$5.0</td>
<td>$55.00</td>
<td>$128.5K</td>
<td>196</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>DVN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/21/24</td>
<td>$5.85</td>
<td>$5.75</td>
<td>$5.85</td>
<td>$47.50</td>
<td>$119.2K</td>
<td>6.8K</td>
<td style="text-align: right;">610</td>
</tr>
<tr>
<td>DVN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$3.7</td>
<td>$3.6</td>
<td>$3.6</td>
<td>$47.50</td>
<td>$76.7K</td>
<td>599</td>
<td style="text-align: right;">213</td>
</tr>
<tr>
<td>DVN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>06/21/24</td>
<td>$6.0</td>
<td>$5.95</td>
<td>$5.95</td>
<td>$47.50</td>
<td>$73.2K</td>
<td>6.8K</td>
<td style="text-align: right;">610</td>
</tr>
</tbody>
</table>
</p>
<h3>About Devon Energy</h3>
<p>Devon Energy, based in Oklahoma City, is one of the largest independent exploration and production companies in North America. The firm's asset base is spread throughout onshore North America and includes exposure to the Delaware, STACK, Eagle Ford, Powder River Basin, and Bakken plays. At year-end 2023, net production totaled roughly 658 thousand boe/d, of which oil and natural gas liquids made up roughly three-quarters of production, with natural gas accounting for the remainder.</p>
<h3>Present Market Standing of Devon Energy</h3>
<ul>
<li>With a trading volume of 2,533,190, the price of DVN is up by 0.1%, reaching $52.66.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 5 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for Devon Energy</h3>
<p>In the last month, 5 experts released ratings on this stock with an average target price of $61.0.</p>
<ul>
<li>Reflecting concerns, an analyst from Barclays lowers its rating to Equal-Weight with a new price target of $59.</li>
<li>An analyst from Truist Securities persists with their Buy rating on Devon Energy, maintaining a target price of $69. </li>
<li>An analyst from JP Morgan has decided to maintain their Overweight rating on Devon Energy, which currently sits at a price target of $62. </li>
<li>An analyst from Stifel persists with their Buy rating on Devon Energy, maintaining a target price of $66. </li>
<li>Maintaining their stance, an analyst from Morgan Stanley continues to hold a Overweight rating for Devon Energy, targeting a price of $49. </li>
</ul>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Devon Energy with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


Behind the Scenes of Devon Energy's Latest Options Trends

<p><a href="https://rivian.com/experience/charging">https://rivian.com/experience/charging</a></p>
<p>&nbsp;</p>


RIVN

Rivian Plans To Make Fast-Charging Network Available To All EVs By Late 2024

<p>BitMEX Co-founder <strong>Arthur Hayes</strong> is encouraging crypto investors to maintain their conviction and stay committed to the <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38463604/bitcoins-consolidation-is-the-calm-before-the-storm-veteran-trader-lark-davis-writes">ongoing bull market</a>. </p>
<p><strong>What Happened:</strong> In his latest blog post titled &#8220;<a href="https://blog.bitmex.com/left-curve/">Left Curve</a>,&#8221; Hayes urges investors not to succumb to the temptation of taking profits prematurely.</p>
<p>Hayes emphasizes the current macroeconomic environment, characterized by major economies debasing their currencies to deleverage government balance sheets. He sees this as the fundamental reason behind the aggressive crypto rally against fiat currencies. </p>
<p>Hayes predicts that this narrative will only gain strength as the sovereign debt bubble begins to burst.</p>
<p>&#8220;Bull markets don&#8217;t come often; it is a travesty when you make the right call but do not maximize your profit potential,&#8221; Hayes <a href="https://blog.bitmex.com/left-curve/">writes</a>. He advocates for a &#8220;Left Curve&#8221; mentality, where investors continuously buy and hold cryptocurrencies throughout the bull market period.</p>
<p>In his concluding remarks, Hayes calls on &#8220;all degens&#8221; to embrace the Left Curve approach, urging investors to maintain their conviction and allow their winning investments to continue growing until real rates turn positive.</p>
<p><figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/digital-assets/"><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/29155259/905735A6-57D3-4874-9AA1-75D037842DB3-2.gif" alt="Benzinga Future of Digital Assets conference" class="wp-image-270548" /></a></figure></p>
<p><em>Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38463604/bitcoins-consolidation-is-the-calm-before-the-storm-veteran-trader-lark-davis-writes">Bitcoin&#8217;s Consolidation Is The &#8216;Calm Before The Storm,&#8217; Veteran Trader Lark Davis Writes</a></em></p>
<p><strong>Why It Matters:</strong> Hayes points to the increasing institutional adoption of <strong>Bitcoin </strong>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>), particularly with the emergence of spot Bitcoin ETFs in the U.S., U.K. and Hong Kong. This recognition from traditional finance underscores Bitcoin&#8217;s potential as a hedge against currency debasement and negative real yields.</p>
<p>Bitcoin, in Hayes&#8217;s view, serves as an escape valve for investors during periods of economic uncertainty, thanks to its finite supply and resilience against currency depreciation.</p>
<p>Looking ahead to the 2024 U.S. presidential election, Hayes predicts further economic stimulus measures aimed at maintaining negative real yields on government bonds, further bolstering Bitcoin&#8217;s appeal as a hedge asset.</p>
<p><strong>What's Next</strong>: The influence of <a href="https://www.benzinga.com/money/is-bitcoin-a-good-investment" target="_blank" rel="noreferrer noopener">Bitcoin as an institutional asset class</a> is expected to be thoroughly explored at Benzinga's upcoming <a href="https://www.benzinga.com/events/digital-assets/agenda/" target="_blank" rel="noreferrer noopener">Future of Digital Assets</a> event on Nov. 19.</p>
<p><em>Read Next: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38461105/bitcoin-could-soar-up-to-1m-says-strike-ceo-jack-mallers-violent-to-the-upside">Bitcoin Could Soar Up To $1M, Says Strike CEO Jack Mallers: &#8216;Violent To The Upside&#8217;</a></em></p>
<p><em>This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.</em></p>
<p><em>Image created using artificial intelligence with Midjourney.</em></p>


Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Arthur Hayes: Bitcoin Bull Market Not Over, Urges Investors To 'Left Curve It'

<p>BMO Capital  analyst Katja Jancic   maintains Reliance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RS#NYSE">RS</a>) with a Outperform and lowers the price target from $355 to $345.</p>


BMO Capital Maintains Outperform on Reliance, Lowers Price Target to $345

Boeing And GKN Aerospace Close Deal For St. Louis Site; Agreement Provides Continuity Of Production And Sustainment Of Critical Parts For F/a-18 And F-15 Programs; Nearly Entire GKN St. Louis Workforce, About 550 People, Have Been Hired By Boeing; Financial Details Will Not Be Disclosed In Accordance With Terms Of Transaction

<p>BMO Capital  analyst Fadi Chamoun   maintains Hub Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUBG#NASDAQ">HUBG</a>) with a Market Perform and lowers the price target from $48 to $45.</p>


HUBG

BMO Capital Maintains Market Perform on Hub Group, Lowers Price Target to $45

<p>BMO Capital  analyst Gerrick Johnson   maintains Harley-Davidson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HOG#NYSE">HOG</a>) with a Outperform and lowers the price target from $50 to $45.</p>


BMO Capital Maintains Outperform on Harley-Davidson, Lowers Price Target to $45

<p>BMO Capital  analyst Evan Seigerman   maintains Bristol-Myers Squibb (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>) with a Market Perform and lowers the price target from $55 to $48.</p>


BMO Capital Maintains Market Perform on Bristol-Myers Squibb, Lowers Price Target to $48

<p>BMO Capital  analyst Jeffrey Silber   maintains ASGN (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASGN#NYSE">ASGN</a>) with a Market Perform and lowers the price target from $95 to $94.</p>


ASGN

BMO Capital Maintains Market Perform on ASGN, Lowers Price Target to $94

<p>BMO Capital  analyst Devin Dodge   maintains Waste Management (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WM#NYSE">WM</a>) with a Market Perform and raises the price target from $207 to $212.</p>


BMO Capital Maintains Market Perform on Waste Management, Raises Price Target to $212

<p>TD Cowen  analyst Jason Gabelman   maintains Equinor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQNR#NYSE">EQNR</a>) with a Hold and raises the price target from $28 to $30.</p>


EQNR

TD Cowen Maintains Hold on Equinor, Raises Price Target to $30

<p>BMO Capital  analyst Devin Dodge   maintains Waste Connections (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WCN#NYSE">WCN</a>) with a Outperform and raises the price target from $182 to $186.</p>


BMO Capital Maintains Outperform on Waste Connections, Raises Price Target to $186

<p>TD Cowen  analyst Marc Bianchi   maintains TechnipFMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FTI#NYSE">FTI</a>) with a Buy and raises the price target from $30 to $32.</p>


TD Cowen Maintains Buy on TechnipFMC, Raises Price Target to $32

<p>BMO Capital  analyst Brian Pitz   maintains Alphabet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) with a Outperform and raises the price target from $185 to $215.</p>


GOOGL

BMO Capital Maintains Outperform on Alphabet, Raises Price Target to $215

WIIM

Impinj shares are trading lower after gaining Thursday on Q1 earnings.

<p>BMO Capital  analyst James Thalacker   maintains CMS Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMS#NYSE">CMS</a>) with a Outperform and raises the price target from $67 to $68.</p>


BMO Capital Maintains Outperform on CMS Energy, Raises Price Target to $68

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>Growth-focused investors may wish to set their sights on the hard-hit <a href="https://investorplace.com/industries/healthcare/biotech/">biotech stocks</a> scene as rates begin to retreat, negative momentum settles and the industry catches a bit of a break for once. Of course, to get a higher chance at outsized gains, one must also have a high risk tolerance and a long-enough investment horizon. Also, when the tides get rough, one needs the confidence and conviction to hang on (or buy on dips).</p>



<p>Indeed, the turbulent seas of the higher-growth corners of the biotech markets will not be for everyone. The potential rewards of owning shares of a firm that&rsquo;s discovered a breakthrough treatment or drug could be considerable. At the same time, if a promising treatment or medication ends up flopping amid clinical trials, the downside could be horrendous.</p>



<p>The good news is that beginner investors can balance the risks with the benefits of advancements in the space. These three biotech ETFs have terrific value as the biotech scene recovers from its painful setback in 2021.</p>



<h2><strong>iShares Biotechnology ETF (IBB)</strong></h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/02/ishares1600-300x169.jpg" alt="iShares by Blackrock sign"><div>Source: Sundry Photography / Shutterstock.com</div></div><p>The <strong>iShares Biotechnology ETF</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/ibb)-stock-quote/"><strong>IBB)</strong></a></span> is a biotech ETF that fits most investors due to its higher concentration in established industry players via the <strong>Nasdaq</strong> exchange. It should be no surprise to see the IBB is the <a href="https://investorplace.com/2023/11/under-the-microscope-3-biotech-stocks-pioneering-tomorrows-cures/">most popular </a>of the biotech ETF batch. </p>



<p>Indeed, the IBB&rsquo;s greater focus on larger-cap blue chips within the biotech universe and the more &ldquo;hands-off&rdquo; passive approach to the fund allow for a relatively reasonable management expense ratio (MER) of 0.45%.</p>



<p>The IBB ETF consists of large-cap biotech darlings that have established themselves over the years. Some of these darlings actually look quite cheap relative to their promising growth pipelines and areas of expertise. <strong>Gilead</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/gild-stock-quote/"><strong>GILD</strong></a></span>), <strong>Regeneron</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/regn-stock-quote/"><strong>REGN</strong></a></span>) and <strong>Amgen</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/amgn-stock-quote/"><strong>AMGN</strong></a></span>) represent a relatively large slice of the overall IBB pie, with a weighting of around 8% each.</p>



<p>Perhaps the biggest reason to opt for IBB over other biotech ETFs is that the top constituents are profitable (the same cannot be said for some of the other biotech ETFs out there!). </p>



<p>Large-cap exposure, profitability and growth make for a rather stacked ETF that should be a top pick for biotech investors this spring.</p>



<h2><strong>SPDR S&amp;P Biotech ETF (XBI)</strong></h2>



<div><img width="300" height="125" src="https://investorplace.com/wp-content/uploads/2022/07/yeung-biotech-300x125.jpg" alt="An illustration of people wearing lab coats working next to a giant beaker representing biotech and gene editing."><div>Source: Ico Maker / Shutterstock.com</div></div><p>If you seek higher growth and have a risk appetite, the <strong>SPDR S&amp;P Biotech ETF</strong> (NYSEARCA:<a href="https://investorplace.com/stock-quotes/xbi-stock-quote/"><strong>XBI</strong></a>) may be more your style. Shares of the XBI ETF are still down more than 43% from its early 2021 peak. Meanwhile, the less-choppy IBB is down around 22% from its own 2021 all-time high. </p>



<p>While both biotech ETFs felt the pressure from the 2021-22 sell-off, the XBI took way more of a hit. As the tides turn in the biotech scene, however, the XBI faces more upside potential if biotech is, in fact, on the cusp of its next bull run. </p>



<p>Like the IBB, the XBI incorporates a passive management approach, which entails a low gross expense ratio of 0.35%. But what&rsquo;s causing the increased choppiness and risk profile if it&rsquo;s not actively wrong managers to blame? </p>



<p>The XBI ETF has less weight in the large-caps and more on the mid-caps and emerging firms in the space. Undoubtedly, odds are you&rsquo;ve never heard of most of the constituents, most of which contribute a weighting of less than 2% of the ETF&rsquo;s weight. </p>



<p>Suppose you seek greater exposure to smaller firms that stand to explode onto the biotech scene (think of firms like <strong>Moderna</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/mrna-stock-quote/"><strong>MRNA</strong></a></span>), which were relatively unknown prior to the COVID-19 pandemic). In that case, the XBI looks more of an <a href="https://investorplace.com/2023/09/dont-miss-the-boom-3-etfs-set-to-explode-higher/">intriguing</a> growth bet than the IBB.</p>



<h2><strong>ARK Genomic Revolution ETF (ARKG)</strong></h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/biotech1600-min-1-300x169.jpg" alt="an image of a microscope, NEXI stock"><div>Source: Shutterstock</div></div><p>Finally, we have the <strong>ARK Genomic Revolution ETF </strong>(CBOE:<a href="https://investorplace.com/stock-quotes/arkg-stock-quote/"><strong>ARKG</strong></a>) for aggressive-growth investors seeking to gain more of an active or &ldquo;hands-on&rdquo; approach to investment management. The MER is quite high at 0.75%, but that&rsquo;s the price of admission if you want the expertise and talent of Cathie Wood and her team over at ARK Invest. If you believe in Wood and the themes she&rsquo;s most bullish on, I&rsquo;m not against keeping tabs on the ARKG ETF at these depths.</p>



<p>Wood seeks to position her fund to profit from some of the most impressive trends within the corner of genomics. Most notably, ARKG invests in companies exposed to fields such as <a href="https://ark-funds.com/funds/arkg/">CRISPR, stem cells and molecular diagnostics</a>. Undoubtedly, some pretty incredible technologies have profound game-changing potential. </p>



<p>Unsurprisingly, <strong>CRISPR Therapeutics </strong>(NASDAQ:<span><a href="https://investorplace.com/stock-quotes/crsp-stock-quote/"><strong>CRSP</strong></a></span>) is the top holding, with a weighting of around 7.8% at the time of writing. </p>



<p>Shares of CRSP and many other ARKG holdings have been through the wringer in recent years. As a result, ARKG shares are down almost 75% from their early 2021 peak. Indeed, the ARKG fund stands out as the most aggressive, growthiest and choppiest of the trio of biotech ETFs in this piece. </p>



<p>If you seek maximal growth and potentially deep value following the vicious crash of 2021, ARKG may be worth watching. Personally, ARKG is too spicy for my investing stomach.</p>



<p><em>On the date of publication, Joey Frenette did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com</em>&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/"><em>Publishing Guidelines</em></a><em>.</em><span><a href="https://investorplace.com/stock-quotes/-stock-quote/"></a></span></p>
<div><p>Joey Frenette is a seasoned investment writer specializing in technology and consumer stocks. Contributing to the Motley Fool Canada, TipRanks, and Barchart, Joey excels in spotting mispriced stocks with long-term growth potential in a fast-paced market.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT793992">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/02/wall-street-legend-issues-urgent-ai-code-red/?cid=MKT781156&amp;eid=MKT793990">&ldquo;America&rsquo;s Top Trader&rdquo; Issues A.I. Code Red: Act Now or Miss Out</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793999">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
<p>The post <a href="https://investorplace.com/2024/03/3-biotech-etfs-overdue-for-a-bounce/">3 Biotech ETFs Overdue for a Bounce</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

3 Biotech ETFs Overdue for a Bounce

Taking Stock: Q2 2024 Equity Market Outlook

GNOM: Genomics Still Waiting For Its 'ChatGPT' Moment

ARKG: Massive Potential, But Not Worth The Risk Yet For These 3 Reasons

Cathie Wood‘s ARK Invest continues to be bullish about Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) and has bought 65,514 shares of the EV major worth $14 million. Wood's A...